(which account for one-half of the antioxidant capacity of plasma) (15 ), of vitamin E (carried in lipoproteins together with cholesterol) and other antioxidants (16 ), and in sepsis, with reduced antioxidant protection by sulfur amino acids (17 ). In sepsis, it is also related to impaired energy and amino acid disposal, which is partly reversed by increasing the amino acid supply (2, 18 ) . Recent studies also suggest that cholesterol becomes an essential substance in extreme illness (19 ) . At present, however, the main clinical implication of severe hypocholesterolemia in acute states is the need for rapid treatment and resolution of the underlying illness.
Gross gene deletions have been reported in 20% of alleles in patients with congenital adrenal hyperplasia (CAH) involving a 21-hydroxylase deficiency (1 ) . This type of deletion occurs in the RCCX module, including the CYP21P, tenascin A (TNXA), RP2, C4B, CYP21, and tenascin B (TNXB) genes, as evidenced by a 30-kb deletion identified by pulse-field electrophoresis (2 ) . Inactivation of the CYP21 gene may also occur through intergenic recombination with transfer of deleterious mutations from the neighboring CYP21P pseudogene. The frequency of gene deletions or conversions in CAH is controversial (3) (4) (5) and is dependent on the population studied. Evidence for gene deletions and/or conversions is traditionally obtained by Southern blot analysis. Multiple probes and separate restriction endonuclease digestions are used. TaqI generates 3.7-kb (functional) and 3.2-kb (pseudogene) fragments, and BglII produces 11-kb (functional) and 12-kb (pseudogene) fragments. These analyses have been used since 1984 (1, 3, (5) (6) (7) (8) (9) . However, the method is indirect and time-consuming, and densitometry of fragments can be prone to error.
To identify the interchange region and improve detection of gene deletions and conversions in the RCCX module (10 -13 ), we have developed a novel Southern blot analysis that uses two restriction endonucleases, AseI and NdeI, and requires only one probe. In addition, we use a PCR product amplified with locus-specific primers covering the TNXB gene to the 5Ј end of CYP21P or CYP21 (Fig. 1A) were used for 6.1-kb PCR product amplification encompassing the TNXB gene and the 5Ј end of the CYP21 gene. The primer CYP749f (5Ј-ggtgctcctggtggctaaaag-3Ј) is located at the 5Ј end of the CYP21P and CYP21 genes (nt 87412-87432; GenBank accession no. AL049547). The 6.1-kb PCR product was directly subjected to TaqI digestion and analyzed by electrophoresis on 0.65% agarose. For identification of CYP21 gene status, the PCR product was analyzed by the amplificationcreated restriction site (ACRS) method (14 ) . The ACRS primer pairing and reaction conditions used for mutation detection, including P30L, IVS-2 Ϫ12A/C3 G, I172N, I236N, V281L, Q318X, and R356W, have been described previously (14 ) .
The strategy for detecting a gene deletion in the RCCX module is shown in ] is either 38.1 or 43.9 kb, depending on whether C4B is present as the long or short form (Fig. 1A) . From the map, two fragments of 21.6 and 11.3 kb were obtained by cleavage with AseI and NdeI in the region as calculated (Fig. 1A) . On probe analysis (with Tena36F2/Tena43R), two fragments of 21.6 and 11.3 kb were obtained in a wild-type individual, as expected (Fig. 1B, lane N) . One patient with suspected gene deletions had an additional 9.3-kb fragment as well as the 21.6-and 11.3-kb fragments (Fig. 1B, lane M) .
Because the 9.3-kb fragment resulted from gene deletions from the TNXA, RP2, and C4B genes (Fig. 1A) , a 6.1-kb PCR product obtained by amplification using the paired primers Tena36F2/CYP749 (Fig. 1A) was derived (Fig. 1D, lane 1) and used to characterize the CYP21 gene by ACRS analysis. Among 18 CAH families, three types of fused CYP21 genes were found, designated CH-1, CH-2, and CH-3 as shown in Fig. 1C . Both CH-1 and CH-2 had been characterized in a previous study (16 ) (Fig. 1C) . On ACRS analysis, CH-3 had mutations at P30L (Fig. 1C, a) , IVS-2 Ϫ12A/C3 G (Fig. 1C, b1), I172N (Fig. 1C, c), I236N  (Fig. 1C, d ), V281L (Fig. 1C, g ), and Q318X (Fig. 1C, j1) as well as nucleotide substitutions at nt Ϫ100, Ϫ103, Ϫ110, and Ϫ123 within the promoter region, similar to those of the CYP21P gene (data not shown). There was no mutation at R356W in CH-3 (Fig. 1C , and data not shown). Therefore, these three partial CYP21P-like genes were distinct chimeric CYP21P/CYP21 genes.
To examine the reaction of these three distinct chimeric molecules to TaqI digestion, the 6.1-kb PCR product was directly subjected to TaqI cleavage analysis. In a wild-type control, 3.7-and 2.4-kb fragments were obtained (Fig. 1D,  lane 2) . The 2.4-kb fragment is a product of exon 45 (nt 83661; GenBank accession no. AL049547) to intron 36 (nt 81171; GenBank accession no. AL049547) of the TNXA and TNXB genes. The three chimeric CYP21P/CYP21 genes, CH-1 (Fig. 1D, lane 3) , CH-2 (Fig. 1D, lane 4) , and CH-3 (Fig. 1D, lane 5) , each contained a 3.2-kb fragment as well as a 3.7-kb fragment.
We have characterized 18 CAH families (17 ) with a suspected deletion of the CYP21 gene by one Southern blot using AseI and NdeI cleavage (data not shown). Each had a 9.3-kb fragment generated by AseI and NdeI cleavage. The novel Southern analysis with one probe demonstrated that the 9.3-kb fragment is a product of deletion in the RCCX module, including the XA, RP2, C4B, and CYP21P/CYP21 genes (Fig. 1A) . With this method, it is clearly unnecessary to perform a Southern blot twice with both TaqI and BglII digestions. We therefore suggest that the 9.3-kb fragment is a marker indicating the existence of the chimeric CYP21P/CYP21 gene. Given the potential for variations and the lack of information about the C4B gene (18 ) in Chinese populations, the size of the RCCX modular deletion may be either 26 or 32 kb (Fig. 1A) . The three distinct chimeric CYP21P/CYP21 genes may result from unequal recombination between the CYP21P and CYP21 genes. We previously suggested (16 ) that both the chi-like sequence GCTGGGG (19 ) and the tandem-repetitive minisatellite consensus GGGCAGGAXG (20 ) might be responsible for gene recombination in the formation of CH-1 and CH-2. In the case of CH-3, a high congruity of the sequence GGGCAGGACT with GGGCAGGAXG located in intron 7 (nt 1950 -1959) probably contributes to the formation of the chimera. We suggest that the base change from C to T (nt 1994) in Q318X is evidence for a breakpoint of unequal crossover in this case. In addition, we found no CYP21 gene deletions. We therefore suggest that what has been assumed to be a deletion of the CYP21 gene may in fact be a chimera.
Southern blot analysis using the TaqI restriction endonuclease-generated 3.7-and 3.2-kb fragments for detection of the CYP21 deletion is time-consuming and involves the use of radioisotopes. Our method is simpler and more convenient in that the 6.1-kb fragment derived by the locus-specific primer is directly subjected to TaqI digestion and is analyzed on an agarose gel without radioisotopic hybridization. It also appears to be more accurate because all three distinct chimeric CYP21P/ CYP21 genes had 3.2-kb fragments (Fig. 1C, lanes 3 and 4) . Simply assuming that the 3.2-kb fragment from conventional Southern analysis (6 ) is a deletion of the CYP21 gene has been shown to be incorrect. The authors of one report have stated that the 3.2-kb fragment analyzed by Southern blotting identified a fused CYP21 gene, but in this study, Southern blotting was performed with radioisotope hybridization and a different endonuclease (8 ) .
In conclusion, the coexistence of 9.3-and 3.2-kb fragments is consistent with a chimeric CYP21P/CYP21 gene. The method of analysis we have described is a novel tool for identification of such a molecule. These chimeric genes were found to occur frequently in CAH caused by steroid 21-hydroxylase deficiency in a Taiwanese (ethnic Chinese) population. The development of benign prostatic hyperplasia (BPH) is dependent on androgens, primarily dihydrotestosterone (DHT) (1 ) . To estimate the activity of 5␣-reductase, which catalyzes the conversion of testosterone to DHT, testosterone and DHT have been quantified in biological samples (2) (3) (4) . Because of their lipophilic properties, they are usually found in the conjugated form, i.e., linked to a hydrophilic sulfuric moiety or ␤-glucuronic acid, which are excreted mainly (Ͼ95%) in human urine. Despite reports of a close association between BPH and testosterone and DHT (1-4 ) , to our knowledge, there is no published simultaneous quantitative data for these metabolites as their glucuronides in the urine of patients with BPH.
Rapid HPLC-Electrospray
The major problem associated with quantification of total steroids is incomplete hydrolysis, attributable mainly to the matrix effects of urine on the efficiency of enzymatic hydrolysis, which reduces the reproducibility of the assay (5, 6 ) . Given that it is often necessary to analyze many samples in a short time with good sensitivity and reproducibility, system throughput is a critical issue for many clinical mass spectrometry (MS) groups. In
